HMGB1 and Sepsis: A high concentration of HMGB1 in the plasma of patients with severe sepsis correlates with a poor prognosis and high mortality, and the pharmacologic inhibition of HMGB1 improved survival in animal models of acute inflammation and severe sepsis (Chen et al., 2004).